Triplex-forming oligonucleotide-orthophenanthroline conjugates for efficient targeted genome modification
The inefficiency of gene modification by homologous recombination can be overcome by the introduction of a double-strand break (DSB) in the target. Engineering the endonucleases needed, however, remains a challenging task that limits widespread application of nuclease-driven gene modification. We re...
Gespeichert in:
Veröffentlicht in: | Proceedings of the National Academy of Sciences - PNAS 2008-07, Vol.105 (28), p.9576-9581 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 9581 |
---|---|
container_issue | 28 |
container_start_page | 9576 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 105 |
creator | Cannata, Fabio Brunet, Erika Perrouault, Loïc Roig, Victoria Ait-Si-Ali, Slimane Asseline, Ulysse Concordet, Jean-Paul Giovannangeli, Carine |
description | The inefficiency of gene modification by homologous recombination can be overcome by the introduction of a double-strand break (DSB) in the target. Engineering the endonucleases needed, however, remains a challenging task that limits widespread application of nuclease-driven gene modification. We report here that conjugates of orthophenanthroline (OP), a DNA cleaving molecule, and triplex-forming oligonucleotides (TFOs), known to bind specific DNA sequences, are synthetic nucleases efficient at stimulating targeted genome modification. We show that in cultured cells, OP-TFO conjugates induce targeted DSBs. An OP-TFO with a unique target was highly efficient, and mutations at the target site were found in [almost equal to]10% of treated cells, including small deletions most likely introduced during DSB repair by nonhomologous end joining. Importantly, we found that when homologous donor DNA was cotransfected, targeted gene modification took place in >1.5% of treated cells. Because triplex-forming sequences are frequent in human and mouse genes, OP-TFO conjugates therefore constitute an important class of site-specific nucleases for targeted gene modification. Harnessing DNA-damaging molecules to predetermined genomic sites, as achieved here, should also provide inroads into mechanisms of DNA repair and cancer. |
doi_str_mv | 10.1073/pnas.0710433105 |
format | Article |
fullrecord | <record><control><sourceid>jstor_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00408029v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>25463015</jstor_id><sourcerecordid>25463015</sourcerecordid><originalsourceid>FETCH-LOGICAL-c546t-a43f71d21a7242db1fbf1fa75019118012ef4b5b1505e1d8f9298ead13ed2eed3</originalsourceid><addsrcrecordid>eNp9ks1v1DAQxSMEotvCmRMQcUBwSJnxxya-IFVVoUgrcaA9W95knPUqsRfHqcp_j6tdWuiBkyW_38x78nNRvEI4Raj5p5030ynUCIJzBPmkWCAorJZCwdNiAcDqqhFMHBXH07QFACUbeF4cYSOVElIsCncV3W6g28qGODrfl2FwffBzO1BIrqMqxLQJuw1549MmZtVT2Qa_nXuTaCrzWEnWutaRT2UysadEXdmTDyOVY-hc1kxywb8onlkzTPTycJ4U118urs4vq9X3r9_Oz1ZVK8UyVUZwW2PH0NRMsG6Ndm3RmloCKsQGkJEVa7lGCZKwa6xiqiHTIaeOEXX8pPi837ub1yN1bc4VzaB30Y0m_tLBOP2v4t1G9-FGM1GL7JIXfNwv2Dwauzxb6bs7AAENMHVzx74_mMXwc6Yp6dFNLQ2D8RTmSTNoFAfGM_juEbgNc_T5ITKDrKlrVBl683f0e_M_dWXg7QHIvT_IIDVrtJL1MhMf_k9oOw9DotuU0dd7dDulEO9ZlmvggPLBzJqgTR_dpK9_5LA8fyNcCgT-G9crxUM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201287719</pqid></control><display><type>article</type><title>Triplex-forming oligonucleotide-orthophenanthroline conjugates for efficient targeted genome modification</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Cannata, Fabio ; Brunet, Erika ; Perrouault, Loïc ; Roig, Victoria ; Ait-Si-Ali, Slimane ; Asseline, Ulysse ; Concordet, Jean-Paul ; Giovannangeli, Carine</creator><creatorcontrib>Cannata, Fabio ; Brunet, Erika ; Perrouault, Loïc ; Roig, Victoria ; Ait-Si-Ali, Slimane ; Asseline, Ulysse ; Concordet, Jean-Paul ; Giovannangeli, Carine</creatorcontrib><description>The inefficiency of gene modification by homologous recombination can be overcome by the introduction of a double-strand break (DSB) in the target. Engineering the endonucleases needed, however, remains a challenging task that limits widespread application of nuclease-driven gene modification. We report here that conjugates of orthophenanthroline (OP), a DNA cleaving molecule, and triplex-forming oligonucleotides (TFOs), known to bind specific DNA sequences, are synthetic nucleases efficient at stimulating targeted genome modification. We show that in cultured cells, OP-TFO conjugates induce targeted DSBs. An OP-TFO with a unique target was highly efficient, and mutations at the target site were found in [almost equal to]10% of treated cells, including small deletions most likely introduced during DSB repair by nonhomologous end joining. Importantly, we found that when homologous donor DNA was cotransfected, targeted gene modification took place in >1.5% of treated cells. Because triplex-forming sequences are frequent in human and mouse genes, OP-TFO conjugates therefore constitute an important class of site-specific nucleases for targeted gene modification. Harnessing DNA-damaging molecules to predetermined genomic sites, as achieved here, should also provide inroads into mechanisms of DNA repair and cancer.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.0710433105</identifier><identifier>PMID: 18599454</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Animals ; Binding sites ; Biochemistry, Molecular Biology ; Biological Sciences ; Cell lines ; Cells ; Cells, Cultured ; Cultured cells ; Deoxyribonucleic acid ; DNA ; DNA Breaks, Double-Stranded ; DNA Breaks, Double-Stranded - drug effects ; Endonucleases ; Gene Targeting ; Gene Targeting - methods ; Genetic Engineering ; Genetic mutation ; Genomes ; Genomics ; HeLa cells ; Humans ; Life Sciences ; Molecular biology ; Molecular Mimicry ; Molecules ; Mutagenesis, Site-Directed ; Mutagenesis, Site-Directed - methods ; Mutation ; Nucleic acids ; Oligonucleotides ; Oligonucleotides - chemistry ; Oligonucleotides - pharmacology ; Phenanthrolines ; Phenanthrolines - chemistry ; Phenanthrolines - pharmacology ; Polymerase chain reaction</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2008-07, Vol.105 (28), p.9576-9581</ispartof><rights>Copyright 2008 The National Academy of Sciences of the United States of America</rights><rights>Copyright National Academy of Sciences Jul 15, 2008</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2008 by The National Academy of Sciences of the USA</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c546t-a43f71d21a7242db1fbf1fa75019118012ef4b5b1505e1d8f9298ead13ed2eed3</citedby><orcidid>0000-0002-1726-4673 ; 0000-0001-8924-4316 ; 0000-0002-7715-8864</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/105/28.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/25463015$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/25463015$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,803,885,27924,27925,53791,53793,58017,58250</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18599454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00408029$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Cannata, Fabio</creatorcontrib><creatorcontrib>Brunet, Erika</creatorcontrib><creatorcontrib>Perrouault, Loïc</creatorcontrib><creatorcontrib>Roig, Victoria</creatorcontrib><creatorcontrib>Ait-Si-Ali, Slimane</creatorcontrib><creatorcontrib>Asseline, Ulysse</creatorcontrib><creatorcontrib>Concordet, Jean-Paul</creatorcontrib><creatorcontrib>Giovannangeli, Carine</creatorcontrib><title>Triplex-forming oligonucleotide-orthophenanthroline conjugates for efficient targeted genome modification</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>The inefficiency of gene modification by homologous recombination can be overcome by the introduction of a double-strand break (DSB) in the target. Engineering the endonucleases needed, however, remains a challenging task that limits widespread application of nuclease-driven gene modification. We report here that conjugates of orthophenanthroline (OP), a DNA cleaving molecule, and triplex-forming oligonucleotides (TFOs), known to bind specific DNA sequences, are synthetic nucleases efficient at stimulating targeted genome modification. We show that in cultured cells, OP-TFO conjugates induce targeted DSBs. An OP-TFO with a unique target was highly efficient, and mutations at the target site were found in [almost equal to]10% of treated cells, including small deletions most likely introduced during DSB repair by nonhomologous end joining. Importantly, we found that when homologous donor DNA was cotransfected, targeted gene modification took place in >1.5% of treated cells. Because triplex-forming sequences are frequent in human and mouse genes, OP-TFO conjugates therefore constitute an important class of site-specific nucleases for targeted gene modification. Harnessing DNA-damaging molecules to predetermined genomic sites, as achieved here, should also provide inroads into mechanisms of DNA repair and cancer.</description><subject>Animals</subject><subject>Binding sites</subject><subject>Biochemistry, Molecular Biology</subject><subject>Biological Sciences</subject><subject>Cell lines</subject><subject>Cells</subject><subject>Cells, Cultured</subject><subject>Cultured cells</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA Breaks, Double-Stranded</subject><subject>DNA Breaks, Double-Stranded - drug effects</subject><subject>Endonucleases</subject><subject>Gene Targeting</subject><subject>Gene Targeting - methods</subject><subject>Genetic Engineering</subject><subject>Genetic mutation</subject><subject>Genomes</subject><subject>Genomics</subject><subject>HeLa cells</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Molecular biology</subject><subject>Molecular Mimicry</subject><subject>Molecules</subject><subject>Mutagenesis, Site-Directed</subject><subject>Mutagenesis, Site-Directed - methods</subject><subject>Mutation</subject><subject>Nucleic acids</subject><subject>Oligonucleotides</subject><subject>Oligonucleotides - chemistry</subject><subject>Oligonucleotides - pharmacology</subject><subject>Phenanthrolines</subject><subject>Phenanthrolines - chemistry</subject><subject>Phenanthrolines - pharmacology</subject><subject>Polymerase chain reaction</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ks1v1DAQxSMEotvCmRMQcUBwSJnxxya-IFVVoUgrcaA9W95knPUqsRfHqcp_j6tdWuiBkyW_38x78nNRvEI4Raj5p5030ynUCIJzBPmkWCAorJZCwdNiAcDqqhFMHBXH07QFACUbeF4cYSOVElIsCncV3W6g28qGODrfl2FwffBzO1BIrqMqxLQJuw1549MmZtVT2Qa_nXuTaCrzWEnWutaRT2UysadEXdmTDyOVY-hc1kxywb8onlkzTPTycJ4U118urs4vq9X3r9_Oz1ZVK8UyVUZwW2PH0NRMsG6Ndm3RmloCKsQGkJEVa7lGCZKwa6xiqiHTIaeOEXX8pPi837ub1yN1bc4VzaB30Y0m_tLBOP2v4t1G9-FGM1GL7JIXfNwv2Dwauzxb6bs7AAENMHVzx74_mMXwc6Yp6dFNLQ2D8RTmSTNoFAfGM_juEbgNc_T5ITKDrKlrVBl683f0e_M_dWXg7QHIvT_IIDVrtJL1MhMf_k9oOw9DotuU0dd7dDulEO9ZlmvggPLBzJqgTR_dpK9_5LA8fyNcCgT-G9crxUM</recordid><startdate>20080715</startdate><enddate>20080715</enddate><creator>Cannata, Fabio</creator><creator>Brunet, Erika</creator><creator>Perrouault, Loïc</creator><creator>Roig, Victoria</creator><creator>Ait-Si-Ali, Slimane</creator><creator>Asseline, Ulysse</creator><creator>Concordet, Jean-Paul</creator><creator>Giovannangeli, Carine</creator><general>National Academy of Sciences</general><general>National Acad Sciences</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1726-4673</orcidid><orcidid>https://orcid.org/0000-0001-8924-4316</orcidid><orcidid>https://orcid.org/0000-0002-7715-8864</orcidid></search><sort><creationdate>20080715</creationdate><title>Triplex-forming oligonucleotide-orthophenanthroline conjugates for efficient targeted genome modification</title><author>Cannata, Fabio ; Brunet, Erika ; Perrouault, Loïc ; Roig, Victoria ; Ait-Si-Ali, Slimane ; Asseline, Ulysse ; Concordet, Jean-Paul ; Giovannangeli, Carine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c546t-a43f71d21a7242db1fbf1fa75019118012ef4b5b1505e1d8f9298ead13ed2eed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Binding sites</topic><topic>Biochemistry, Molecular Biology</topic><topic>Biological Sciences</topic><topic>Cell lines</topic><topic>Cells</topic><topic>Cells, Cultured</topic><topic>Cultured cells</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA Breaks, Double-Stranded</topic><topic>DNA Breaks, Double-Stranded - drug effects</topic><topic>Endonucleases</topic><topic>Gene Targeting</topic><topic>Gene Targeting - methods</topic><topic>Genetic Engineering</topic><topic>Genetic mutation</topic><topic>Genomes</topic><topic>Genomics</topic><topic>HeLa cells</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Molecular biology</topic><topic>Molecular Mimicry</topic><topic>Molecules</topic><topic>Mutagenesis, Site-Directed</topic><topic>Mutagenesis, Site-Directed - methods</topic><topic>Mutation</topic><topic>Nucleic acids</topic><topic>Oligonucleotides</topic><topic>Oligonucleotides - chemistry</topic><topic>Oligonucleotides - pharmacology</topic><topic>Phenanthrolines</topic><topic>Phenanthrolines - chemistry</topic><topic>Phenanthrolines - pharmacology</topic><topic>Polymerase chain reaction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cannata, Fabio</creatorcontrib><creatorcontrib>Brunet, Erika</creatorcontrib><creatorcontrib>Perrouault, Loïc</creatorcontrib><creatorcontrib>Roig, Victoria</creatorcontrib><creatorcontrib>Ait-Si-Ali, Slimane</creatorcontrib><creatorcontrib>Asseline, Ulysse</creatorcontrib><creatorcontrib>Concordet, Jean-Paul</creatorcontrib><creatorcontrib>Giovannangeli, Carine</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cannata, Fabio</au><au>Brunet, Erika</au><au>Perrouault, Loïc</au><au>Roig, Victoria</au><au>Ait-Si-Ali, Slimane</au><au>Asseline, Ulysse</au><au>Concordet, Jean-Paul</au><au>Giovannangeli, Carine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Triplex-forming oligonucleotide-orthophenanthroline conjugates for efficient targeted genome modification</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2008-07-15</date><risdate>2008</risdate><volume>105</volume><issue>28</issue><spage>9576</spage><epage>9581</epage><pages>9576-9581</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>The inefficiency of gene modification by homologous recombination can be overcome by the introduction of a double-strand break (DSB) in the target. Engineering the endonucleases needed, however, remains a challenging task that limits widespread application of nuclease-driven gene modification. We report here that conjugates of orthophenanthroline (OP), a DNA cleaving molecule, and triplex-forming oligonucleotides (TFOs), known to bind specific DNA sequences, are synthetic nucleases efficient at stimulating targeted genome modification. We show that in cultured cells, OP-TFO conjugates induce targeted DSBs. An OP-TFO with a unique target was highly efficient, and mutations at the target site were found in [almost equal to]10% of treated cells, including small deletions most likely introduced during DSB repair by nonhomologous end joining. Importantly, we found that when homologous donor DNA was cotransfected, targeted gene modification took place in >1.5% of treated cells. Because triplex-forming sequences are frequent in human and mouse genes, OP-TFO conjugates therefore constitute an important class of site-specific nucleases for targeted gene modification. Harnessing DNA-damaging molecules to predetermined genomic sites, as achieved here, should also provide inroads into mechanisms of DNA repair and cancer.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>18599454</pmid><doi>10.1073/pnas.0710433105</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-1726-4673</orcidid><orcidid>https://orcid.org/0000-0001-8924-4316</orcidid><orcidid>https://orcid.org/0000-0002-7715-8864</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 2008-07, Vol.105 (28), p.9576-9581 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_00408029v1 |
source | MEDLINE; JSTOR Archive Collection A-Z Listing; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | Animals Binding sites Biochemistry, Molecular Biology Biological Sciences Cell lines Cells Cells, Cultured Cultured cells Deoxyribonucleic acid DNA DNA Breaks, Double-Stranded DNA Breaks, Double-Stranded - drug effects Endonucleases Gene Targeting Gene Targeting - methods Genetic Engineering Genetic mutation Genomes Genomics HeLa cells Humans Life Sciences Molecular biology Molecular Mimicry Molecules Mutagenesis, Site-Directed Mutagenesis, Site-Directed - methods Mutation Nucleic acids Oligonucleotides Oligonucleotides - chemistry Oligonucleotides - pharmacology Phenanthrolines Phenanthrolines - chemistry Phenanthrolines - pharmacology Polymerase chain reaction |
title | Triplex-forming oligonucleotide-orthophenanthroline conjugates for efficient targeted genome modification |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A06%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Triplex-forming%20oligonucleotide-orthophenanthroline%20conjugates%20for%20efficient%20targeted%20genome%20modification&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Cannata,%20Fabio&rft.date=2008-07-15&rft.volume=105&rft.issue=28&rft.spage=9576&rft.epage=9581&rft.pages=9576-9581&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.0710433105&rft_dat=%3Cjstor_hal_p%3E25463015%3C/jstor_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201287719&rft_id=info:pmid/18599454&rft_jstor_id=25463015&rfr_iscdi=true |